Inflammatix Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Burlingame,
Total Funding:$136.1M
Industry:Biotech
Founded:2016
Lead Investor(s):N/A

Industry Ranking

State Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Inflammatix's estimated annual revenue is currently $12.9M per year.(?)
  • Inflammatix's estimated revenue per employee is $155,000
  • Inflammatix's total funding is $136.1M.

Employee Data

  • Inflammatix has 83 Employees.(?)
  • Inflammatix grew their employee count by 89% last year.
  • Inflammatix currently has 8 job openings.

Inflammatix, Inc. is a venture-backed startup located in the San Francisco Bay Area that is building novel diagnostics for acute infections and sepsis based on our unique immune biomarkers. Approximately $10 billion / year is spent trying to diagnose acute infections, but current technologies that focus on ᅢᄁ¬ツᆲᅨワfinding the bugᅢᄁ¬ツᆲ¬トᄁ are (1) slow and (2) effective in fewer than 30% of cases. Inflammatixᅢツᅡᅠhas developed a statistically rigorous,ᅢツᅡᅠextensively validated diagnostic method that 'reads' the immune system. Our HostDxᅢᄁ¬ダᅡᄁ tests report clinically actionable information on theᅢツᅡᅠpresence, type (bacterial or viral), and severity of infection in all patients. They have been extensively validated and published in top-tier medical journals. After this initial product, Inflammatix plans to develop and commercialize additional novel diagnostic tests to address significant unmet clinical needs.

keywords:Biotechnology, Medical Devices, Diagnostics, Bioinformatics